What Happens to Patients with Rheumatoid Arthritis? The Long-term Outcome of Treatment

Overview

Journal Clin Rheumatol

Publisher Springer

Specialty Rheumatology

Date 1988 Sep 1

PMID 3147831

Citations 9

Authors

T D Spector

D L Scott

Affiliations

Soon will be listed here.

Citing Articles

Methotrexate in rheumatoid arthritis is frequently effective, even if re-employed after a previous failure.

Kapral T, Stamm T, Machold K, Montag K, Smolen J, Aletaha D Arthritis Res Ther. 2006; 8(2):R46.

PMID: 16507172 PMC: 1526609. DOI: 10.1186/ar1902.

Safety and efficacy of disease-modifying anti-rheumatic agents: focus on the benefits and risks of etanercept.

Fleischmann R, Iqbal I, Nandeshwar P, Quiceno A Drug Saf. 2002; 25(3):173-97.

PMID: 11945114 DOI: 10.2165/00002018-200225030-00004.

Assessment of quality of life in rheumatoid arthritis: methods and implications.

Bendtsen P, Akerlind I, Hornquist J Pharmacoeconomics. 1994; 5(4):286-98.

PMID: 10147238 DOI: 10.2165/00019053-199405040-00004.

Treatment perspectives in rheumatoid arthritis: a descriptive study in a Swedish healthcare district.

Bendtsen P, Bjurulf P, Trell E, Lindstrom F, Larsson J Pharmacoeconomics. 1994; 5(5):399-407.

PMID: 10147232 DOI: 10.2165/00019053-199405050-00006.

Pharmacological intervention in older patients with rheumatoid arthritis. Quality of life aspects.

Bendtsen P, Akerlind I, Hornquist J Drugs Aging. 1995; 7(5):338-46.

PMID: 8573989 DOI: 10.2165/00002512-199507050-00002.

References

Iannuzzi L, Dawson N, Zein N, Kushner I . Does drug therapy slow radiographic deterioration in rheumatoid arthritis?. N Engl J Med. 1983; 309(17):1023-8. DOI: 10.1056/NEJM198310273091704. View

Young A, Corbett M, Brook A . The clinical assessment of joint inflammatory activity in rheumatoid arthritis related to radiological progression. Rheumatol Rehabil. 1980; 19(1):14-9. DOI: 10.1093/rheumatology/19.1.14. View

Pepys M . C-reactive protein fifty years on. Lancet. 1981; 1(8221):653-7. DOI: 10.1016/s0140-6736(81)91565-8. View

Masotti G, Galanti G, Poggesi L, Abbate R, NERI SERNERI G . Differential inhibition of prostacyclin production and platelet aggregation by aspirin. Lancet. 1979; 2(8154):1213-7. DOI: 10.1016/s0140-6736(79)92334-1. View

Dixon J, Bird H, Pickup M, WRIGHT V . A human model screening system for the detection of specific antirheumatic activity. Semin Arthritis Rheum. 1982; 12(2):185-90. DOI: 10.1016/0049-0172(82)90059-2. View

Duthie J, BROWN P, TRUELOVE L, BARAGAR F, LAWRIE A . COURSE AND PROGNOSIS IN RHEUMATOID ARTHRITIS. A FURTHER REPORT. Ann Rheum Dis. 1964; 23:193-204. PMC: 1030892. DOI: 10.1136/ard.23.3.193. View

Amos R, Constable T, Crockson R, Crockson A, MCCONKEY B . Rheumatoid arthritis: relation of serum C-reactive protein and erythrocyte sedimentation rates to radiographic changes. Br Med J. 1977; 1(6055):195-7. PMC: 1604383. DOI: 10.1136/bmj.1.6055.195. View

Scott D, Coulton B, Chapman J, Bacon P, POPERT A . The long-term effects of treating rheumatoid arthritis. J R Coll Physicians Lond. 1983; 17(1):79-85. PMC: 5370976. View

Scott D, Coulton B, Bacon P, POPERT A . Methods of X-ray assessment in rheumatoid arthritis: a re-evaluation. Br J Rheumatol. 1985; 24(1):31-9. DOI: 10.1093/rheumatology/24.1.31. View

10.

Buckland-Wright J . X-ray assessment of activity in rheumatoid disease. Br J Rheumatol. 1983; 22(1):3-10. DOI: 10.1093/rheumatology/22.1.3. View

11.

Mutru O, Koota K, Isomaki H . Causes of death in autopsied RA patients. Scand J Rheumatol. 1976; 5(4):239-40. DOI: 10.3109/03009747609099912. View

12.

Dawes P, Fowler P, Clarke S, Fisher J, Lawton A, Shadforth M . Rheumatoid arthritis: treatment which controls the C-reactive protein and erythrocyte sedimentation rate reduces radiological progression. Br J Rheumatol. 1986; 25(1):44-9. DOI: 10.1093/rheumatology/25.1.44. View

13.

Pullar T, Hunter J, Capell H . Does second-line therapy affect the radiological progression of rheumatoid arthritis?. Ann Rheum Dis. 1984; 43(1):18-23. PMC: 1001209. DOI: 10.1136/ard.43.1.18. View

14.

Horslev-Petersen K, Bentsen K, Junker P, Lorenzen I . Serum amino-terminal type III procollagen peptide in rheumatoid arthritis. Relationship to disease activity, treatment, and development of joint erosions. Arthritis Rheum. 1986; 29(5):592-9. DOI: 10.1002/art.1780290503. View

15.

Fleming A, Crown J, Corbett M . Incidence of joint involvement in early rheumatoid arthritis. Rheumatol Rehabil. 1976; 15(2):92-6. DOI: 10.1093/rheumatology/15.2.92. View

16.

Rasker J, Cosh J . Cause and age at death in a prospective study of 100 patients with rheumatoid arthritis. Ann Rheum Dis. 1981; 40(2):115-20. PMC: 1000690. DOI: 10.1136/ard.40.2.115. View

17.

Monson R, HALL A . Mortality among arthritics. J Chronic Dis. 1976; 29(7):459-67. DOI: 10.1016/0021-9681(76)90086-2. View

18.

Fries J, Spitz P, Kraines R, HOLMAN H . Measurement of patient outcome in arthritis. Arthritis Rheum. 1980; 23(2):137-45. DOI: 10.1002/art.1780230202. View

19.

KAPLAN D . The age of death of the parents of patients with rheumatoid arthritis: a preliminary study. J Rheumatol. 1986; 13(5):903-6. View

20.

Pincus T, Callahan L, Vaughn W . Questionnaire, walking time and button test measures of functional capacity as predictive markers for mortality in rheumatoid arthritis. J Rheumatol. 1987; 14(2):240-51. View